PLANO, Texas--(BUSINESS WIRE)--VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has received U.S. Food and Drug Administration (FDA) approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD station which includes the ability to process additional standard screening views. Together, the CAD system updates provide radiologists with faster processing time, enhanced workflow and improved parallel architecture.
Help employers find you! Check out all the jobs and post your resume.
